Skip to main content

Glucometrics and Measuring Blood Glucose in Critically Ill Patients

  • Chapter
  • First Online:
Monitoring Technologies in Acute Care Environments

Abstract

Glucose homeostasis is dysregulated in critical illness, and “stress hyperglycemia” carries significant morbidity and is an independent risk factor for poor outcome after ICU admission. Clinicians, various regulatory organizations, and clinical societies have therefore drafted guidelines for the management of hyperglycemia in the critically ill. The institution of “tight glycemic control” utilizing insulin infusions to achieve blood glucose levels of 80–110 mg/dl was widely accepted following the publication of improved outcomes in critically ill patients in the initial Van den Berghe study in 2001. Many studies following, however, were unable to reproduce the outcomes realized in the first study and raised concern regarding increased frequency of hypoglycemia on intensive insulin therapy regimens. The purpose of this chapter is to evaluate the various methodologies utilized in ICUs to measure glucose levels that are then used to make treatment decisions regarding management of the hyperglycemia of critical illness. A comparison of point-of-care (POC) testing with glucose meters, arterial blood gas (ABG) measurements, and central laboratory (CLM) testing is explored with a focus on how measurements are made, accuracy, cost, and convenience.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Van den Berghe G. Molecular biology: a timely tool for further unraveling the “diabetes of stress”. Crit Care Med. 2001;29(4):910–1.

    Article  PubMed  Google Scholar 

  2. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.

    Article  PubMed  Google Scholar 

  3. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041–7.

    Article  PubMed  CAS  Google Scholar 

  4. Devos P, Preiser JC, Mélot C, Glucontrol Steering Committee. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycemia: final results of the glucontrol study [abstract]. Intensive Care Med. 2007;33:S189.

    Google Scholar 

  5. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.

    Article  Google Scholar 

  6. Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971–80.

    PubMed  Google Scholar 

  7. Müller D. Studien liber ein neues Enzym Glykoseoxydase. I. Biochem Z. 1928;199:136–70.

    Google Scholar 

  8. Keston AS. Abstracts, 129th National Meeting of the American Chemical Society, Dallas. April 1956, pp. 31C–32C, Abstract No. 76.

    Google Scholar 

  9. U.S. Department of Health and Human Services. Food and Drug Administration; Center for Disease Control and Prevention. Current CLIA regulations. FDA. 510(k) Number: k051727.

    Google Scholar 

  10. College of American Pathologists 1995 Survey, Set C3-C, Specimen C-14.

    Google Scholar 

  11. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403–9.

    Article  PubMed  Google Scholar 

  12. Neese JW, Duncan P, Bayse D, Robinson M, Cooper T, Stewart C. Development and evaluation of a hexokinase/glucose-6-phosphate dehydrogenase procedure for use as a national glucose reference method. HEW Publication No. (CDC) 77-8330. Atlanta: CDC; 1976.

    Google Scholar 

  13. Mendosa D. Meter memories. How Tom, Dick, and Charlie did it. Diabet Wellness Lett. 2000:1(6). www.mendosa.com/memories.htm

  14. Bernstein RK. Dr. Bernstein’s diabetes solution. A complete guide to achieving normal blood sugars. London: Little Brown; 1997.

    Google Scholar 

  15. Kilgore ML, Steindel SJ, Smith JA. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. J Healthc Manag. 1999;44(3):207–15. The Free Library 01 May 1999. 24 October 2012.

    PubMed  CAS  Google Scholar 

  16. Yeaw J, Lee WC, Aagren M, Christensen T. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes. J Manag Care Pharm. 2012;18(1):21–32.

    PubMed  Google Scholar 

  17. Khan AI, Vasquez Y, Gray J, Wians Jr FH, Kroll MH. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med. 2006;130:1527–32.

    PubMed  CAS  Google Scholar 

  18. Painter PC, Cope JY, Smith JL. Reference ranges, table 41-20. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry. 2nd ed. Philadelphia: W.B. Saunders Company; 1994.

    Google Scholar 

  19. Connelly NR, Magee M, Kiessling B. The use of the iSTAT portable analyzer in patients undergoing cardiopulmonary bypass. J Clin Monit. 1996;12(4):311–5.

    Article  PubMed  CAS  Google Scholar 

  20. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care. 2006;10(5):R135.

    Article  PubMed  Google Scholar 

  21. Twomey PJ. Plasma glucose measurement with the Yellow Springs Glucose 2300 STAT and the Olympus AU640. J Clin Pathol. 2004;57(7):752–4.

    Article  PubMed  CAS  Google Scholar 

  22. ISO 15197. In vitro diagnostic test systems – requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva: International Organization for Standardization; 2003.

    Google Scholar 

  23. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Disease Control and Prevention. Current CLIA regulations. 2004. Cited 11 Aug 2009.

    Google Scholar 

  24. Burtis CA, Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. St. Louis: Elsevier/Saunders; 2006. p. 868–71.

    Google Scholar 

  25. Beneteau-Burnat B, Bocque MC, Lorin A, Martin C, Vaubourdolle M. Evaluation of the blood gas analyzer Gem PREMIER 3000. Clin Chem Lab Med. 2004;42:96–101.

    Article  PubMed  CAS  Google Scholar 

  26. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem. 2002;48:994–1003.

    PubMed  CAS  Google Scholar 

  27. D’Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Külpmann WR, et al.; IFCC-SD-WG-SEPOCT. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med. 2006;44(12):1486–90.

    Google Scholar 

  28. D’Orazio P, Burnett RW, Fogh-Andersen N, Jacobs E, Kuwa K, Kulpmann WR, et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem. 2005;51:1573–6.

    Article  PubMed  Google Scholar 

  29. Blake DR, Nathan DM. Point-of-care testing for diabetes. Crit Care Nurs Q. 2004;27:150–61.

    Article  PubMed  Google Scholar 

  30. Larsson-Conn U. Differences between capillary and venous blood glucose during oral glucose tolerance tests. Scand J Clin Lab Invest. 1976;36:805–8.

    Article  Google Scholar 

  31. Burtis CA, Ashwood ER. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia: W.B. Sanders; 1999.

    Google Scholar 

  32. Olansky L, Kennedy L. Finger-stick glucose monitoring: issues of accuracy and specificity. Diabetes Care. 2010;33:948–9.

    Article  PubMed  Google Scholar 

  33. Wens R, Taminne M, Devriendt J, Collart F, Broeders N, Mestrez F, Germanos H, et al. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int. 1998;18:603–9.

    PubMed  CAS  Google Scholar 

  34. Oyibo SO, Pritchard GM, McLay L, James E, Laing I, Gokal R, Boulton AJ. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease. Diabet Med. 2002;19:693–6.

    Article  PubMed  Google Scholar 

  35. Mendoza-Hernandez G, Minauro F, Rendon JL. Aggregation, dissociation, and unfolding of glucose dehydrogenase during urea denaturation. Biochim Biophys Acta. 2000;1478:221–31.

    Article  PubMed  CAS  Google Scholar 

  36. Mehmet S, Quan G, Thomas S, Goldsmith D. Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis. Diabet Med. 2001;18:679–82.

    Article  PubMed  CAS  Google Scholar 

  37. Arabadjief D, Nichols JH. Assessing glucose meter accuracy. Curr Med Res Opin. 2006;22(11):2167–74.

    Article  PubMed  CAS  Google Scholar 

  38. Bergenstal RM. Evaluating the accuracy of modern glucose meters. Insulin. 2008;3(1):5–14.

    Article  Google Scholar 

  39. Haller MJ, Shuster JJ, Schatz D, Melker RJ. Adverse impact of temperature and humidity on blood glucose monitoring reliability: a pilot study. Diabetes Technol Ther. 2007;9(1):1–9.

    PubMed  CAS  Google Scholar 

  40. Pitkin AD, Rice MJ. Challenges to glycemic measurement in the perioperative and critically ill patient: a review. J Diabetes Sci Technol. 2009;3(6):1270–81.

    PubMed  Google Scholar 

  41. Silberberg JL. Performance degradation of electronic medical devices due to electromagnetic interference. Compliance Eng. 1993;10:25.

    Google Scholar 

  42. U.S. Department Of Health And Human Services; Public Health Service Food and Drug Administration Center for Disease Control and Prevention. 1996. www.fda.gov/MedicalDevices/.../GuidanceDocuments/ucm094134.htm.

  43. Balion C, Grey V, Ismaila A, Blatz S, Seidlitz W. Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter. BMC Pediatr. 2006;6:28.

    Article  PubMed  Google Scholar 

  44. Wiene RK. The effect of hematocrit on reagent strip tests for glucose. Diabet Med. 1991;1(8):172–5.

    Article  Google Scholar 

  45. Evans JR, McIntosh JP, Hartung H, Anderson C, Sawers JS. Falsely low blood glucose readings by a blood glucose meter system. Diabet Med. 1994;11(3):326–7.

    Article  PubMed  CAS  Google Scholar 

  46. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem. 1989;35(2):315–7.

    PubMed  CAS  Google Scholar 

  47. Weissman M, Klein B. Evaluation of glucose determinations in untreated serum samples. Clin Chem. 1958;4(5):420–2.

    PubMed  CAS  Google Scholar 

  48. Gardner RM. Computerized management of intensive care patients. MD Comput. 1986;391:36–51.

    Google Scholar 

  49. Mraovic B, Schwenk ES, Epstein RH. Intraoperative accuracy of a point-of-care glucose meter compared with simultaneous central laboratory measurements. J Diabetes Sci Technol. 2012;6(3):541–6.

    PubMed  Google Scholar 

  50. Ha JS, Gam J, Choi SL, Oh KH, Ro HS, Song JJ, Shin CS, Lee SG. Quantitative analyses of individual sugars in mixture using FRET-based biosensors. Biotechnol Prog. 2012;28(5):1376–83.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liza M. Weavind MBBCh, FCCM .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Evans, G.E., Crabtree, D., Weavind, L.M. (2014). Glucometrics and Measuring Blood Glucose in Critically Ill Patients. In: Ehrenfeld, J., Cannesson, M. (eds) Monitoring Technologies in Acute Care Environments. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8557-5_35

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8557-5_35

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8556-8

  • Online ISBN: 978-1-4614-8557-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics